{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:11:36Z","timestamp":1778717496684,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s10549-021-06162-2","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T14:04:07Z","timestamp":1615817047000},"page":"715-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases"],"prefix":"10.1007","volume":"187","author":[{"given":"Madeleine","family":"Hetterich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gerken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Ortmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth C.","family":"Inwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Klinkhammer-Schalke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holm","family":"Eggemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9006-4029","authenticated-orcid":false,"given":"Atanas","family":"Ignatov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"key":"6162_CR1","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3","volume":"52","author":"B Fisher","year":"1983","unstructured":"Fisher B, Bauer M, Wickerham DL et al (1983) Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update Cancer 52:1551\u20131557. https:\/\/doi.org\/10.1002\/1097-0142(19831101)52:9%3c1551::AID-CNCR2820520902%3e3.0.CO;2-3","journal-title":"An NSABP update Cancer"},{"key":"6162_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s13193-010-0018-6","volume":"1","author":"HA Hatoum","year":"2010","unstructured":"Hatoum HA, Jamali FR, El-Saghir NS et al (2010) Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Indian J Surg Oncol 1:68\u201375. https:\/\/doi.org\/10.1007\/s13193-010-0018-6","journal-title":"Indian J Surg Oncol"},{"key":"6162_CR3","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/1097-0142(20010915)92:6<1378::AID-CNCR1460>3.0.CO;2-Y","volume":"92","author":"G Viale","year":"2001","unstructured":"Viale G, Maiorano E, Mazzarol G et al (2001) Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 92:1378\u20131384. https:\/\/doi.org\/10.1002\/1097-0142(20010915)92:6%3c1378::AID-CNCR1460%3e3.0.CO;2-Y","journal-title":"Cancer"},{"key":"6162_CR4","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ejso.2006.04.001","volume":"32","author":"M van der Heiden-Loo","year":"2006","unstructured":"van der Heiden-Loo M, Bezemer PD, Hennipman A et al (2006) Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol 32:710\u2013714. https:\/\/doi.org\/10.1016\/j.ejso.2006.04.001","journal-title":"Eur J Surg Oncol"},{"key":"6162_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546\u2013553. https:\/\/doi.org\/10.1056\/NEJMoa012782","journal-title":"N Engl J Med"},{"key":"6162_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927\u2013933. https:\/\/doi.org\/10.1016\/S1470-2045(10)70207-2","journal-title":"Lancet Oncol"},{"key":"6162_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10549-008-9913-8","volume":"113","author":"AJG Maaskant","year":"2009","unstructured":"Maaskant AJG, Van De Poll-Franse LV, Voogd AC et al (2009) Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat 113:173\u2013179. https:\/\/doi.org\/10.1007\/s10549-008-9913-8","journal-title":"Breast Cancer Res Treat"},{"key":"6162_CR8","first-page":"151","volume-title":"TNM classification of malignant tumours","author":"C Wittekind","year":"2016","unstructured":"Wittekind C (2016) TNM classification of malignant tumours, 8th edn. Wiley, New York, pp 151\u2013158","edition":"8"},{"key":"6162_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/A:1012938825396","volume":"70","author":"VCG Tjan-Heijnen","year":"2001","unstructured":"Tjan-Heijnen VCG, Bult P, De Widt-Levert LM et al (2001) Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat 70:81\u201388. https:\/\/doi.org\/10.1023\/A:1012938825396","journal-title":"Breast Cancer Res Treat"},{"key":"6162_CR10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1136\/jcp.52.12.922","volume":"52","author":"G Cserni","year":"1999","unstructured":"Cserni G (1999) Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J Clin Pathol 52:922\u2013924. https:\/\/doi.org\/10.1136\/jcp.52.12.922","journal-title":"J Clin Pathol"},{"key":"6162_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/00000658-199509000-00016","volume":"222","author":"AE Giuliano","year":"1995","unstructured":"Giuliano AE, Dale PS, Turner RR et al (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394\u2013401. https:\/\/doi.org\/10.1097\/00000658-199509000-00016","journal-title":"Ann Surg"},{"key":"6162_CR12","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1099::AID-CNCR22>3.0.CO;2-7","volume":"88","author":"DL Weaver","year":"2000","unstructured":"Weaver DL, Krag DN, Ashikaga T et al (2000) Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 88:1099\u20131107. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(20000301)88:5%3c1099::AID-CNCR22%3e3.0.CO;2-7","journal-title":"Cancer"},{"key":"6162_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10549-008-0021-6","volume":"114","author":"N Patani","year":"2009","unstructured":"Patani N, Mokbel K (2009) The clinical significance of sentinel lymph node micrometastasis in breast cancer. Breast Cancer Res Treat 114:393\u2013402. https:\/\/doi.org\/10.1007\/s10549-008-0021-6","journal-title":"Breast Cancer Res Treat"},{"key":"6162_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/nejmoa0904832","volume":"361","author":"M de Boer","year":"2009","unstructured":"de Boer M, van Deurzen CH, van Dijck JA et al (2009) Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J M 361:653\u2013663. https:\/\/doi.org\/10.1056\/nejmoa0904832","journal-title":"N Engl J M"},{"key":"6162_CR15","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1200\/JCO.2008.19.0686","volume":"27","author":"NM Hansen","year":"2009","unstructured":"Hansen NM, Grube B, Ye X et al (2009) Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol 27:4679\u20134684. https:\/\/doi.org\/10.1200\/JCO.2008.19.0686","journal-title":"J Clin Oncol"},{"key":"6162_CR16","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1600-0463.2007.apm_442.x","volume":"115","author":"D Grabau","year":"2007","unstructured":"Grabau D, Jensen MB, Rank F, Blichert-Toft M (2007) Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival. APMIS 115:828\u2013837. https:\/\/doi.org\/10.1111\/j.1600-0463.2007.apm_442.x","journal-title":"APMIS"},{"key":"6162_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/annonc\/mdn535","volume":"20","author":"PD Gobardhan","year":"2009","unstructured":"Gobardhan PD, Elias SG, Madsen EVE et al (2009) Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study. Ann Oncol 20:41\u201348. https:\/\/doi.org\/10.1093\/annonc\/mdn535","journal-title":"Ann Oncol"},{"key":"6162_CR18","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1245\/s10434-007-9513-6","volume":"14","author":"SL Chen","year":"2007","unstructured":"Chen SL, Hoehne FM, Giuliano AE (2007) The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 14:3378\u20133384. https:\/\/doi.org\/10.1245\/s10434-007-9513-6","journal-title":"Ann Surg Oncol"},{"key":"6162_CR19","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2020) S3-Leitlinie Fr\u00fcherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Version 4.3, AWMF, Registernummer: 032-045OL. pp 101, 143\u2013168."},{"key":"6162_CR20","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1245\/s10434-009-0660-9","volume":"16","author":"I Langer","year":"2009","unstructured":"Langer I, Guller U, Viehl CT et al (2009) Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Ann Surg Oncol 16:3366\u20133374. https:\/\/doi.org\/10.1245\/s10434-009-0660-9","journal-title":"Ann Surg Oncol"},{"key":"6162_CR21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.breast.2012.03.008","volume":"21","author":"AJ Maaskant-Braat","year":"2012","unstructured":"Maaskant-Braat AJ, Voogd AC, van de Poll-Franse LV et al (2012) Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node. Breast 21:524\u2013528. https:\/\/doi.org\/10.1016\/j.breast.2012.03.008","journal-title":"Breast"},{"key":"6162_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-019-05387-3","author":"C Taubenhansl","year":"2019","unstructured":"Taubenhansl C, Ortmann O, Gerken M et al (2019) Guideline-concordant chemotherapy in patients with hormone receptor-positive and node-positive, early breast cancer leads to better overall and metastases-free survival with limited benefit in elderly patients. Arch Gynecol Obstet. https:\/\/doi.org\/10.1007\/s00404-019-05387-3","journal-title":"Arch Gynecol Obstet"},{"key":"6162_CR23","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00432-018-2711-8","volume":"144","author":"T Ignatov","year":"2018","unstructured":"Ignatov T, Eggemann H, Costa SD et al (2018) Endometrial cancer subtypes are associated with different patterns of recurrence. J Cancer Res Clin Oncol 144:2011\u20132017. https:\/\/doi.org\/10.1007\/s00432-018-2711-8","journal-title":"J Cancer Res Clin Oncol"},{"key":"6162_CR24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ygyno.2019.07.018","volume":"154","author":"A Ignatov","year":"2019","unstructured":"Ignatov A, Lebius C, Ignatov T et al (2019) Lymph node micrometastases and outcome of endometrial cancer. Gynecol Oncol 154:475\u2013479. https:\/\/doi.org\/10.1016\/j.ygyno.2019.07.018","journal-title":"Gynecol Oncol"},{"key":"6162_CR25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M et al (2008) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"key":"6162_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/joim.12084","volume":"274","author":"AJ Redig","year":"2013","unstructured":"Redig AJ, Mcallister SS (2013) Breast cancer as a systemic disease: a view of metastasis. J Intern Med 274:113\u2013126. https:\/\/doi.org\/10.1111\/joim.12084","journal-title":"J Intern Med"},{"key":"6162_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1245\/s10434-008-0229-z","volume":"16","author":"G Gill","year":"2009","unstructured":"Gill G (2009) Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 16:266\u2013275. https:\/\/doi.org\/10.1245\/s10434-008-0229-z","journal-title":"Ann Surg Oncol"},{"key":"6162_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10549-006-9192-1","volume":"99","author":"A Goyal","year":"2006","unstructured":"Goyal A, Newcombe RG, Chhabra A, Mansel RE (2006) Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer: results of the ALMANAC validation phase. Breast Cancer Res Treat 99:203\u2013208. https:\/\/doi.org\/10.1007\/s10549-006-9192-1","journal-title":"Breast Cancer Res Treat"},{"key":"6162_CR29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881\u2013888. https:\/\/doi.org\/10.1016\/S1470-2045(07)70278-4","journal-title":"Lancet Oncol"},{"key":"6162_CR30","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S1470-2045(06)70947-0","volume":"7","author":"U Veronesi","year":"2006","unstructured":"Veronesi U, Paganelli G, Viale G et al (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7:983\u2013990. https:\/\/doi.org\/10.1016\/S1470-2045(06)70947-0","journal-title":"Lancet Oncol"},{"key":"6162_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/106689690401200402","volume":"12","author":"M Rivera","year":"2004","unstructured":"Rivera M, Merlin S, Hoda RS et al (2004) Minimal involvement of sentinel lymph node in breast carcinoma: prevailing concepts and challenging problems. Int J Surg Pathol 12:301\u2013306. https:\/\/doi.org\/10.1177\/106689690401200402","journal-title":"Int J Surg Pathol"},{"key":"6162_CR32","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/j.suronc.2011.06.006","volume":"20","author":"M Salhab","year":"2011","unstructured":"Salhab M, Patani N, Mokbel K (2011) Sentinel lymph node micrometastasis in human breast cancer: an update. Surg Oncol 20:e195\u2013e206. https:\/\/doi.org\/10.1016\/j.suronc.2011.06.006","journal-title":"Surg Oncol"},{"key":"6162_CR33","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/cncr.20934","volume":"103","author":"A Chagpar","year":"2005","unstructured":"Chagpar A, Middleton LP, Sahin AA et al (2005) Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 103:1581\u20131586. https:\/\/doi.org\/10.1002\/cncr.20934","journal-title":"Cancer"},{"key":"6162_CR34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1075-122X.2006.00267.x","volume":"12","author":"HJ Kahn","year":"2006","unstructured":"Kahn HJ, Hanna WM, Chapman JAW et al (2006) Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system. Breast J 12:294\u2013301. https:\/\/doi.org\/10.1111\/j.1075-122X.2006.00267.x","journal-title":"Breast J"},{"key":"6162_CR35","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0002-9610(01)00722-X","volume":"182","author":"SL Wong","year":"2001","unstructured":"Wong SL, Chao C, Edwards MJ et al (2001) The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. Am J Surg 182:330\u2013334. https:\/\/doi.org\/10.1016\/S0002-9610(01)00722-X","journal-title":"Am J Surg"},{"key":"6162_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10549-010-1086-6","volume":"127","author":"AJ Maaskant-Braat","year":"2011","unstructured":"Maaskant-Braat AJ, Van De Poll-Franse LV, Voogd AC et al (2011) Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Res Treat 127:195\u2013203. https:\/\/doi.org\/10.1007\/s10549-010-1086-6","journal-title":"Breast Cancer Res Treat"},{"key":"6162_CR37","doi-asserted-by":"publisher","first-page":"CRA504","DOI":"10.1200\/jco.2010.28.18_suppl.cra504","volume":"28","author":"R Cote","year":"2010","unstructured":"Cote R, Giuliano AE, Hawes D et al (2010) ACOSOG Z0010: a multicenter prognostic study of sentinel node (SN) and bone marrow (BM) micrometastases in women with clinical T1\/T2 N0 M0 breast cancer. J Clin Oncol 28:CRA504. https:\/\/doi.org\/10.1200\/jco.2010.28.18_suppl.cra504","journal-title":"J Clin Oncol"},{"key":"6162_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/01.sla.0000149305.23322.3c","volume":"241","author":"I Langer","year":"2005","unstructured":"Langer I, Marti WR, Guller U et al (2005) Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 241:152\u2013158. https:\/\/doi.org\/10.1097\/01.sla.0000149305.23322.3c","journal-title":"Ann Surg"},{"key":"6162_CR39","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/path.829","volume":"193","author":"C Colpaert","year":"2001","unstructured":"Colpaert C, Vermeulen P, Jeuris W et al (2001) Early distant relapse in \u201cnode-negative\u201d breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour. J Pathol 193:442\u2013449. https:\/\/doi.org\/10.1002\/path.829","journal-title":"J Pathol"},{"key":"6162_CR40","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/sj.bjc.6600070","volume":"86","author":"RR Millis","year":"2002","unstructured":"Millis RR, Springall R, Lee AHS et al (2002) Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br J Cancer 86:396\u2013401. https:\/\/doi.org\/10.1038\/sj.bjc.6600070","journal-title":"Br J Cancer"},{"key":"6162_CR41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/bjc.1992.306","volume":"66","author":"I De Mascarel","year":"1992","unstructured":"De Mascarel I, Bonichon F, Coindre JM, Trojani M (1992) Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 66:523\u2013527. https:\/\/doi.org\/10.1038\/bjc.1992.306","journal-title":"Br J Cancer"},{"key":"6162_CR42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jamcollsurg.2007.08.024","volume":"206","author":"CE Cox","year":"2008","unstructured":"Cox CE, Kiluk JV, Riker AI et al (2008) Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg 206:261\u2013268. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2007.08.024","journal-title":"J Am Coll Surg"},{"key":"6162_CR43","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jamcollsurg.2008.10.036","volume":"208","author":"J Reed","year":"2009","unstructured":"Reed J, Rosman M, Verbanac KM et al (2009) Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective east Carolina University\/Anne Arundel Medical Center Sentinel Node Mult. J Am Coll Surg 208:333\u2013340. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2008.10.036","journal-title":"J Am Coll Surg"},{"key":"6162_CR44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10549-009-0446-6","volume":"118","author":"E Montagna","year":"2009","unstructured":"Montagna E, Viale G, Rotmensz N et al (2009) Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure. Breast Cancer Res Treat 118:385\u2013394. https:\/\/doi.org\/10.1007\/s10549-009-0446-6","journal-title":"Breast Cancer Res Treat"},{"key":"6162_CR45","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1007\/s00268-018-4725-4","volume":"42","author":"HW Bae","year":"2018","unstructured":"Bae HW, Yoon KH, Kim JH et al (2018) Impact of micrometastatic axillary nodes on survival of breast cancer patients with tumors \u22642 cm. World J Surg 42:3969\u20133978. https:\/\/doi.org\/10.1007\/s00268-018-4725-4","journal-title":"World J Surg"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06162-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-021-06162-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06162-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T17:07:12Z","timestamp":1623517632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-021-06162-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["6162"],"URL":"https:\/\/doi.org\/10.1007\/s10549-021-06162-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]},"assertion":[{"value":"6 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all patients before treatment. The local Ethics Committee of the Otto-von-Guericke University, Magdeburg, Germany ruled that no formal ethics approval was required for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}